The best surgery for pelvic organ prolapse?
Women suffering from pelvic organ prolapse might be best served by surgery that preserves their uterus rather than removing it, a landmark clinical trial reports.
19 hours ago
0
3
Diagnosis: News and Research on Treatment Outcome
MeSH tree: E01.789.800
Stopping myeloma maintenance after two years shows no survival loss in trial
For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration ...
Jul 16, 2026
0
5
Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NETs
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
Jul 7, 2026
0
5
Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
Jul 6, 2026
0
3
EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic lymphocytic leukemia
For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...
Jul 2, 2026
0
3
Investigators report promising results from Phase II trial of targeted therapy for rare bile duct cancer
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically ...
Jul 1, 2026
0
5
AI support tool improves clinician decisions in real-world primary care trial
A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not significantly change short-term ...
Jun 26, 2026
0
7
As patients move through injury care, well-intentioned changes can backfire
Global health policymakers should focus on the way entire health care systems work together, argue researchers in new findings. Improving one element does not always create better outcomes if the wider system is not ready.
Jun 21, 2026
0
3
FDA approves Welireg with pembrolizumab for renal cell carcinoma
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
AI model proves to be a heavyweight in tumor assessment: Mesothelioma patients and physicians benefit
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians in evaluating treatment response in pleural mesothelioma. Far more accurate than the current international ...
Jun 17, 2026
0
5
